Ad
EWL Quote Trading Chart iShares Inc MSCI Switzerland
Quote | iShares Inc MSCI Switzerland (NYSE:EWL)
| Last: | $48.83 |
|---|---|
| Change Percent: | 0.04% |
| Open: | $48.77 |
| Close: | $48.83 |
| High: | $48.925 |
| Low: | $48.74 |
| Volume: | 185,362 |
| Last Trade Date Time: | 01/24/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
EWL Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $48.83 | $48.77 | $48.83 | $48.925 | $48.74 | 185,362 | 01-24-2025 |
| $48.79 | $48.53 | $48.79 | $48.81 | $48.34 | 259,083 | 01-23-2025 |
| $48.44 | $48.47 | $48.44 | $48.475 | $48.32 | 294,161 | 01-22-2025 |
| $48.35 | $47.83 | $48.35 | $48.36 | $47.79 | 489,627 | 01-21-2025 |
| $47.17 | $47.29 | $47.17 | $47.38 | $47.165 | 487,358 | 01-20-2025 |
| $47.17 | $47.29 | $47.17 | $47.38 | $47.165 | 487,358 | 01-17-2025 |
| $47.11 | $46.94 | $47.11 | $47.26 | $46.81 | 268,061 | 01-16-2025 |
| $46.6 | $46.64 | $46.6 | $46.66 | $46.42 | 842,625 | 01-15-2025 |
| $46.33 | $46.3 | $46.33 | $46.38 | $46.045 | 196,121 | 01-14-2025 |
| $46.16 | $45.83 | $46.16 | $46.17 | $45.81 | 478,194 | 01-13-2025 |
| $46.41 | $46.61 | $46.41 | $46.62 | $46.26 | 242,777 | 01-10-2025 |
| $47 | $46.73 | $47 | $47.08 | $46.615 | 925,710 | 01-09-2025 |
| $47 | $46.73 | $47 | $47.08 | $46.615 | 925,710 | 01-08-2025 |
| $46.87 | $46.94 | $46.87 | $47.08 | $46.735 | 331,685 | 01-07-2025 |
| $46.52 | $46.34 | $46.52 | $46.7 | $46.23 | 428,350 | 01-06-2025 |
| $46.26 | $46.04 | $46.26 | $46.26 | $45.86 | 331,746 | 01-03-2025 |
| $45.85 | $46.22 | $45.85 | $46.2201 | $45.8 | 513,584 | 01-02-2025 |
| $45.96 | $46.42 | $45.96 | $46.42 | $45.915 | 553,898 | 01-01-2025 |
| $45.96 | $46.42 | $45.96 | $46.42 | $45.915 | 553,898 | 12-31-2024 |
| $46.2 | $46.1 | $46.2 | $46.35 | $45.9 | 276,156 | 12-30-2024 |
News, Short Squeeze, Breakout and More Instantly...
iShares Inc MSCI Switzerland Company Name:
EWL Stock Symbol:
NYSE Market:
Ad
-
Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate...
-
Edwards Lifesciences Corporation (NYSE: EW) will discuss the company’s focused strategy for long-term sustainable growth, provide an update on its technology pipeline to serve more patients and share financial guidance today during its annual investor conference. Edwards enters 2025, its f...
-
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended Sept. 30, 2024. Highlights and Outlook Q3 sales from continuing operations grew 9%; constant currency 1 sales grew 10% Q3 TAVR sales grew 6%; constant currency 1 sales grew 7% ...